Asset Manager

Updated:

BioScience Managers Limited

BioScience Managers Limited was established as an investment firm concentrating on the life sciences sector.

BioScience Managers Limited

BioScience Managers Limited was established as an investment firm concentrating on the life sciences sector. Its founding and wealth origin are not publicly detailed. The firm maintains offices in three cities: Guangzhou, Vancouver, and Melbourne, reflecting a presence across key biotech regions in Asia-Pacific and North America. The firm’s strategy centers on direct investments and partnerships within biotech, pharmaceuticals, healthcare services, and medical devices. It invests across the value chain, from early-stage research to commercial-stage companies. While specific portfolio companies are not disclosed in available records, the sector focus suggests a mandate aligned with therapeutic innovation and healthcare delivery. The firm does not publicly disclose AUM, team size, or named principals. Its multi-city office structure indicates a cross-border operational model, likely targeting opportunities in both developed and emerging life sciences markets. No recent operational events are verifiable from public sources. The firm’s structural differentiator is its multi-continent office footprint in three distinct life sciences hubs — Guangzhou, Vancouver, and Melbourne — which may provide diversified deal flow and regional expertise. However, the lack of public information limits further assessment of its governance or strategic posture.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

Country

China

City

Guangzhou, Vancouver, Melbourne

Corporate office

Additional offices

Guangzhou · Vancouver · Melbourne

Sector focus

BiotechPharmaceuticalsHealthcare ServicesMedical Devices

Frequently asked questions

What sectors does BioScience Managers Limited invest in?

The firm focuses on the life sciences sector, including biotech, pharmaceuticals, healthcare services, and medical devices. It invests across the value chain, from early-stage research to commercial-stage companies (per the firm's office locations and sector description).

Where are BioScience Managers Limited's offices located?

The firm has offices in Guangzhou (China), Vancouver (Canada), and Melbourne (Australia). This multi-city presence spans three continents, providing access to different biotech and healthcare markets (public record).

Does BioScience Managers Limited disclose its assets under management?

No. The firm does not publicly disclose AUM, and the number is not available in any known public or proprietary sources. Its investment scale remains undisclosed.

Who are the principals or investment team at BioScience Managers Limited?

The firm does not publicly list its principals or investment professionals. No named individuals are available in public records or the firm's own communications.

Is BioScience Managers Limited a single-family office or an asset manager?

The firm is structured as an asset manager, not a family office. It does not publicly associate with any specific family wealth (public record).

How does BioScience Managers Limited deploy capital?

The firm makes direct investments and forms partnerships within the life sciences sector. Deal structure details, such as co-investment or fund commitments, are not specified in public sources.

What is the investment stage focus of BioScience Managers Limited?

The firm targets opportunities across the biotech and pharmaceutical value chain, implying a stage-agnostic approach that can include early-stage research, clinical development, and commercial-stage companies (per the firm's sector description).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo